Periodic Reporting for period 1 - p53-REACT (Dynamics of p53 mutant reactivation and the anti-carcinogenic action of engineered resveratrol analogues)

The p53-REACT project (“named after p53 REACTivation”) tackled a critical challenge in cancer therapy by targeting the mutated p53 protein, implicated in over half of all cancer cases worldwide. While chemotherapy and radiotherapy are common treatments, they often fail in...